DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCorporate Action

AksharChem India Limited — Change in Directors/KMP/SMP/Auditor/RTA

NSE 1 hr ago·11 Aug 2026, 6:38 am

Aksharchem India

AksharChem India Limited has informed stock exchanges about changes in its key management personnel and statutory auditors. This update indicates a restructuring of the company's leadership team and its external compliance partners.

For investors, such changes can sometimes signal internal shifts in strategy or governance. While not always a cause for concern, it is important to monitor how these new appointments align with the company's future plans and operational stability.

Investors should watch for the company's official announcements regarding the specific roles being filled. Keeping an eye on operational performance and future guidance will help determine if these changes are neutral or impactful.